| Literature DB >> 33083656 |
Justin M Low1, Nicole J H Lee2, Grant Sprow3, Alisha Chlebik4, Arthur Olch4,5, Kaleb Darrow6, Kristine Bowlin4, Kenneth K Wong4,5.
Abstract
PURPOSE: A bolus is usually required to ensure radiation dose coverage of extensive superficial tumors of the scalp or skull. Oftentimes, these boluses are challenging to make and are nonreproducible, so an easier method was sought. METHODS AND MATERIALS: Thermoplastic sheets are widely available in radiation oncology clinics and can serve as bolus. Two template cutouts were designed for anterior and posterior halves to encompass the cranium of children and adults.Entities:
Year: 2020 PMID: 33083656 PMCID: PMC7557138 DOI: 10.1016/j.adro.2020.03.017
Source DB: PubMed Journal: Adv Radiat Oncol ISSN: 2452-1094
Figure 1Bolus for patient treated in case report 1. (A) Lateral view of complete bolus. (B) Frontal view of anterior half of bolus. (C) Frontal view of posterior half of bolus fused with headrest.
Figure 2Bolus for patient treated in case report 2. (A) Lateral view of complete bolus. (B) Frontal view of anterior half of bolus. (C) Frontal view of posterior half of bolus. (D) Color wash showing 1800 to 2200 cGy dose to scalp.
Figure 3(A) Scalp and cranium radiation therapy using modulation (SCRUM) on foam head. (B) Bolus on foam head. (C) Volunteer facing forward. (D) Posterior bolus to demonstrate possible separate use of anterior and posterior halves.
Figure 4(A) Posterior template. (B) Formed thermoplastic using template. (C) Anterior template. (D) Formed thermoplastic using template.
Figure 5(A) Axial view of phantom head with custom thermoplastic bolus with widest air gap depicted. (B) Axial view of SuperFlab bolus with widest air gap depicted. (C) Thermoplastic bolus setup on head phantom. (D) SuperFlab setup on head phantom.
Figure 6(A) Dose histogram comparing thermoplastic versus SuperFlab with about 3% difference at D95%. (B) Color wash of thermoplastic showing prescribed dose of 95% to 113%. (C) Color wash of SuperFlab showing prescribed dose of 95% to 113%.